Vivo Capital

Vivo Capital as of March 31, 2018

Portfolio Holdings for Vivo Capital

Vivo Capital holds 34 positions in its portfolio as reported in the March 2018 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Menlo Therapeutics 21.4 $151M 4.0M 37.58
Ascendis Pharma A S (ASND) 20.1 $142M 2.2M 65.40
Biohaven Pharmaceutical Holding 7.5 $53M 2.0M 25.76
Codexis (CDXS) 4.8 $34M 3.1M 11.00
Apellis Pharmaceuticals (APLS) 4.6 $32M 1.5M 22.11
Verona Pharma Plc ads (VRNA) 4.2 $30M 1.5M 20.00
Aclaris Therapeutics (ACRS) 4.1 $29M 1.6M 17.52
Homology Medicines 3.1 $22M 1.2M 18.70
Nabriva Therapeutics 2.9 $21M 4.1M 5.03
Amyris (AMRSQ) 2.7 $19M 2.8M 6.69
Eiger Biopharmaceuticals 2.5 $18M 1.8M 9.85
Strongbridge Bioph shs usd 2.4 $17M 1.9M 8.85
Kala Pharmaceuticals 2.3 $17M 1.0M 15.83
Kadmon Hldgs 2.0 $14M 3.3M 4.25
Arrowhead Pharmaceuticals (ARWR) 1.9 $14M 1.9M 7.21
Selecta Biosciences (RNAC) 1.6 $11M 1.1M 10.19
Cymabay Therapeutics 1.5 $10M 800k 12.99
Aimmune Therapeutics 1.4 $9.8M 307k 31.83
Genocea Biosciences 1.2 $8.6M 8.2M 1.05
Soleno Therapeutics 1.0 $7.3M 4.0M 1.81
Aurinia Pharmaceuticals (AUPH) 0.9 $6.3M 1.2M 5.19
Zai Lab (ZLAB) 0.9 $6.1M 284k 21.35
Sierra Oncology 0.7 $5.0M 2.4M 2.07
Regenxbio Inc equity us cm (RGNX) 0.7 $4.9M 164k 29.85
Foamix Pharmaceuticals 0.6 $4.4M 855k 5.13
Zogenix 0.6 $4.2M 105k 40.05
Agile Therapeutics 0.6 $3.9M 1.5M 2.57
Biopharmx 0.5 $3.7M 16M 0.23
Madrigal Pharmaceuticals (MDGL) 0.5 $3.2M 27k 116.79
Trevena 0.4 $2.8M 1.7M 1.64
Kalvista Pharmaceuticals (KALV) 0.4 $2.8M 300k 9.48
Akari Therapeutics 0.1 $629k 346k 1.82
Sunesis Pharmaceuticals Inc Ne 0.1 $532k 196k 2.72
Soleno Therapeutics, Inc. warrant 0.0 $23k 189k 0.12